Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769613012 | Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3769614018 | Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has precise active ingredient | Cilastatin sodium (substance) | true | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength numerator value (attribute) | 250 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength numerator value (attribute) | 250 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has precise active ingredient | imipénem (substance) | true | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Imipenem anhydrous (substance) | true | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Cilastatin | true | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | est un(e) (attribut) | Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | est un(e) (attribut) | médicament contenant imipénem et cilastatine | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a pour principe actif (attribut) | bêta-lactamines | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a pour principe actif (attribut) | Carbapenem (substance) | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a pour principe actif (attribut) | Cilastatin | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a pour principe actif (attribut) | imipénem (substance) | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | a une forme pharmaceutique (attribut) | Powder for solution for injection | true | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | est un(e) (attribut) | Cilastatin- and imipenem-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR